CNC insider ownership: who sold, why, and what they still hold

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Theodore Pienkos Corporate Controller & CAO	1,092	$69.41	8.0%	13K	Sep 15, 2026	Sep 16, 2026

What stands out

Kenneth Burdick sold 35% of vested holdings: 146K shares for $7.7M, none under a disclosed plan.Largest sale, Jun 10, 2026

Christopher Koster sold $6.9M of stock with no disclosed trading plan. The filings don't state a reason.Largest such sale, Aug 26, 2026

Selling picked up in the last 90 days: officers and directors sold 104K shares, against an average of 48K per 90 days earlier in the period. Most of it was Christopher Koster (104K shares in the last 90 days); 0% of these sales were under disclosed plans.Christopher Koster: largest recent sale, Aug 26, 2026

Percentages cover 17 of 21 officers and directors. 4 are left out

Left out: Christopher Koster (holdings couldn't be fully reconciled); Daniel Finke, Lauren Tyler and Paul Diaz (held no vested shares at the start).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Each bar is 100% of that person's own stake; not comparable between people. The stake is the vested shares held at the start of the period (Oct 9, 2025); the gold part is what they sold.

SoldRest of starting stake

Kenneth Burdick

Director

35% · $7.7MNo plan disclosed

Christopher Koster

Secretary & General Counsel

Sold $6.9M (plan status beside the amount). Share of stake not shown: holdings couldn't be fully reconciled. Why

$6.9MNo plan disclosed

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled

Common questions

Is the Centene Corporation CEO selling stock?

No. Sarah London reported no open-market sales in the past 12 months.

Why are Centene Corporation insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 0% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 100% had no disclosed plan. A trading plan schedules sales in advance.

Are any Centene Corporation insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

How much of their stake did Centene Corporation insiders sell?

About 8.9% overall. As a group they still hold 96% of their starting shares. The biggest individual seller, Kenneth Burdick, gave up 35% of starting holdings. That covers the 12 months to Oct 9, 2026 and counts vested shares reported on SEC Forms 3, 4 and 5, which is not an insider's whole wealth.

The evidence

Who sold2 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Kenneth Burdick Director	$7.7M 146K shares	35%	No plan disclosed
Christopher Koster Secretary & General Counsel	$6.9M 104K shares	i No percentage: holdings couldn't be fully reconciled.	No plan disclosed

The full ownership picture20 of 21 insiders fully reconciled · 19 officers and directors

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 9, 2025

Sold

Held Oct 9, 2026

Still held

Kenneth Burdick

Unvested RSUs stated in footnotes are excluded from owned shares. New Form 3 filed 2022-01-14; earlier filings set aside.

Director

421K

−146K

280K

66%

Vesting, gifts, unvested awards and holding lines for Kenneth Burdick

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.
New Form 3 filed 2022-01-14; earlier filings set aside.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	334,793	193,094
Burdick Family LLC	Common Stock	86,498	86,498

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$80.57	Feb 7, 2032	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Frederick Eppinger

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

354K

364K

no sales

Vesting, gifts, unvested awards and holding lines for Frederick Eppinger

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	353,788	363,748

Andrew Asher

Minor difference of -67,985 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Unvested RSUs stated in footnotes are excluded from owned shares.

Chief Financial Officer

273K

299K

no sales

Vesting, gifts, unvested awards and holding lines for Andrew Asher

0shares vested or exercised

0gifted (net of own trusts)

−15Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	273,395	299,339

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
13,449	$81.85	Dec 15, 2031	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Reconciliation: minor difference of -67,985 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Sarah London

Minor difference of -141,103 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Unvested RSUs stated in footnotes are excluded from owned shares.

Chief Executive Officer, Director

253K

299K

no sales

Vesting, gifts, unvested awards and holding lines for Sarah London

0shares vested or exercised

0gifted (net of own trusts)

−36Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	253,277	299,078

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
13,449	$81.85	Dec 15, 2031	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Reconciliation: minor difference of -141,103 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Christopher Koster

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -26,709.467 shares on Jan 26, 2026 (Direct). See the filing Sales and other transactions for Christopher Koster are complete.

Secretary & General Counsel

n/a

−104K

n/a

Vesting, gifts, unvested awards and holding lines for Christopher Koster

0shares vested or exercised

0gifted (net of own trusts)

−9.1Kwithheld by the company for taxes

3K → 3Kunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -26,709.467 shares on Jan 26, 2026 (Direct). The balances below are as reported, not verified totals.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	227,337	18,980
Spouse	Common Stock	100	100

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,690	$81.85	Dec 15, 2031	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Michael Carson

Unvested RSUs stated in footnotes are excluded from owned shares. Started reporting during the period; starting holdings are from the Form 3.

Group President, Medicare&Spec

66K

10K

no sales

Vesting, gifts, unvested awards and holding lines for Michael Carson

0shares vested or exercised

0gifted (net of own trusts)

556 → 0unvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	65,263	9,135
Spouse	Common Stock	825	825

Theodore Samuels II

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

48K

54K

no sales

Vesting, gifts, unvested awards and holding lines for Theodore Samuels II

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,626	21,804
family trust	Common Stock	32,000	32,000

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$80.57	Feb 27, 2032	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

James Dallas

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

42K

46K

no sales

Vesting, gifts, unvested awards and holding lines for James Dallas

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	40,303	43,882
a revocable family trust	Common Stock	1,693	1,693

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$62.81	Feb 3, 2030	$41K

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Christopher Coughlin

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

39K

45K

no sales

Vesting, gifts, unvested awards and holding lines for Christopher Coughlin

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	8,709	15,302
Grantor Retained Annuity Trust	Common Stock	30,054	30,054

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$80.57	Feb 7, 2032	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Katie Casso

Minor difference of -9,236 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Unvested RSUs stated in footnotes are excluded from owned shares.

Corporate Controller & CAO

34K

38K

no sales

Vesting, gifts, unvested awards and holding lines for Katie Casso

0shares vested or exercised

0gifted (net of own trusts)

−3.4Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	33,774	38,036

Reconciliation: minor difference of -9,236 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Jessica Blume

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

25K

29K

no sales

Vesting, gifts, unvested awards and holding lines for Jessica Blume

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	24,786	28,365
a revocable family trust	Common Stock	250	250

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
20,000	$55.29	Apr 24, 2028	$232K

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Susan Smith

Minor difference of -9,651 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Unvested RSUs stated in footnotes are excluded from owned shares.

Chief Operating Officer

22K

31K

no sales

Vesting, gifts, unvested awards and holding lines for Susan Smith

0shares vested or exercised

0gifted (net of own trusts)

−3.4Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	22,349	31,155

Reconciliation: minor difference of -9,651 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Thomas Greco

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

19K

no sales

Vesting, gifts, unvested awards and holding lines for Thomas Greco

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	19,309	19,309

Wayne DeVeydt

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

16K

no sales

Vesting, gifts, unvested awards and holding lines for Wayne DeVeydt

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	15,944	15,944

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$80.57	Feb 7, 2032	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Theodore Pienkos

Unvested RSUs stated in footnotes are excluded from owned shares. Started reporting during the period; starting holdings are from the Form 3.

Corporate Controller & CAO

14K

15K

no sales

Vesting, gifts, unvested awards and holding lines for Theodore Pienkos

0shares vested or exercised

0gifted (net of own trusts)

−1.1Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	13,703	14,988

Tanya McNally

Minor difference of -2,073 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Unvested RSUs stated in footnotes are excluded from owned shares.

Chief People Officer

8.5K

15K

no sales

Vesting, gifts, unvested awards and holding lines for Tanya McNally

0shares vested or exercised

0gifted (net of own trusts)

−4.5Kwithheld by the company for taxes

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	8,531	15,204

Reconciliation: minor difference of -2,073 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Monte Ford

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

7.3K

11K

no sales

Vesting, gifts, unvested awards and holding lines for Monte Ford

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	7,256	10,835

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,000	$86.49	Dec 9, 2032	$0

Estimate: options held × ($66.90 − strike price), using the most recent insider trade price on Form 4 (Aug 26, 2026), not a market close.

Kenneth Tanji

Unvested RSUs stated in footnotes are excluded from owned shares.

Director

2.4K

9.1K

no sales

Vesting, gifts, unvested awards and holding lines for Kenneth Tanji

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	2,369	9,101

Lauren Tyler

Unvested RSUs stated in footnotes are excluded from owned shares. Started reporting during the period; starting holdings are from the Form 3.

Director

543

no sales

Vesting, gifts, unvested awards and holding lines for Lauren Tyler

0shares vested or exercised

0gifted (net of own trusts)

none reportedunvested awards, start → end

Unvested RSUs stated in footnotes are excluded from owned shares.
Started reporting during the period; starting holdings are from the Form 3.

Held through	Share class	Oct 9, 2025	Oct 9, 2026
Direct	Common Stock	0	543
Direct	No Securities Beneficially Owned	0	0

20 of 21 insiders fully reconciled: starting holdings plus reported transactions match ending holdings (15 exactly, 5 with a minor or footnoted difference). For 1 we show sales but not holdings; the ! icon on that row explains why. Percentages cover 17 of 21 officers and directors. Left out: Christopher Koster (holdings couldn't be fully reconciled); Daniel Finke, Lauren Tyler and Paul Diaz (held no vested shares at the start). "Still held" compares ending with starting vested shares; a plus sign means the holding grew.

What explains the selling$14.6M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $14.6M across 250,110 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

No plan disclosed · $14.6M

Sales with no 10b5-1 plan and no tax reference in the filing. $7.7M of it is Kenneth Burdick. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Kenneth Burdick, Jun 10, 2026

Taxes

72,715 shares ($2.6M) were withheld by the company for taxes, which isn't a market sale.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Kenneth Burdick Director	146K	$7.7M	0%	53%	Dec 3, 2025 to Jun 10, 2026
Christopher Koster Secretary & General Counsel	104K	$6.9M	0%	47%	Aug 18, 2026 to Aug 26, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$2.6M	$0	$0	$2.6M
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$5.2M	$0	$0	$5.2M
Jul 2026	$0	$0	$0	$0
Aug 2026	$6.9M	$0	$0	$6.9M
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

In line with the past 5 years. 2 insiders sold; the average is 5 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 9, 2026 Latest 12 months	250K	2	$14.6M
Oct 9, 2025 1 year earlier	0	0	$0
Oct 9, 2024 2 years earlier	31K	3	$2.4M
Oct 10, 2023 3 years earlier	1.4K	1	$93K
Oct 10, 2022 4 years earlier	214K	12	$16.4M
Oct 10, 2021 5 years earlier	596K	10	$41.0M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty1 insider whose holdings couldn't be fully reconciled

Christopher Koster: holdings couldn't be fully reconciled (difference of -26,588 shares). Balance changed without a matching transaction, and the footnote does not state the amount: -26,709.467 shares on Jan 26, 2026 (Direct). Filing, Jan 26, 2026

Footnote: "This award includes 50,770 restricted stock units that vest in three annual installments beginning on March 15, 2027. This award also includes 76,155 performance stock units reported at target level performance. The actual number of performance stock units that will vest on March 15, 2029 ranges from 0% to 200% of the reported target performance stock units based on the Company's stock price performance for the final 20 trading days of 2025, compared to the final 60 trading days of 2028. | This Form 4/A is being filed to amend the Form 4 filed on January 28, 2026 to remove from the total holdi"

Andrew Asher: minor difference of -67,985 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Sarah London: minor difference of -141,103 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Katie Casso: minor difference of -9,236 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Susan Smith: minor difference of -9,651 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Tanya McNally: minor difference of -2,073 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer).

Inferred rename: "trust" is treated as the same holder as "a revocable trust for the benefit of Mr", because the old name was never reported again and the new one opened with the same balance (40,984 shares). Old name, new name

Inferred rename: "Ditmore 2002 Charitable Remainder Unit Trust" is treated as the same holder as "Ditmore Family Management Company LLC", because the old name was never reported again and the new one opened with the same balance (796,000 shares). Old name, new name

Inferred rename: "a revocable family trust" is treated as the same holder as "family trust", because the old name was never reported again and the new one opened with the same balance (23,000 shares). Old name, new name

Inferred typo: the share class "Common Sock" is treated as the same class as "Common Stock" on 1 holding line, because the two spellings are nearly identical and each balance carried over exactly. Example (Carol Goldman, 112,252 shares): old title, new title

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology2,294 filings from SEC EDGAR, and how we read them

All 2,294 Forms 3, 4 and 5 filed for Centene Corporation (SEC CIK 1071739) from Jan 10, 2002 to Sep 30, 2026, retrieved from SEC EDGAR on Oct 9, 2026. Prices are the ones reported in each filing, often weighted averages. 23 older filings exist only on paper and could not be read.

Probable 2-for-1 stock split on or before Dec 16, 2004 (first filing that shows post-split balances). Splits aren't reported as transactions; 6 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-1 stock split on or before Feb 4, 2015 (first filing that shows post-split balances). Splits aren't reported as transactions; 7 holding lines changed by exactly this ratio, so earlier share counts are restated.

Probable 2-for-1 stock split on or before Jan 4, 2019 (first filing that shows post-split balances). Splits aren't reported as transactions; 23 holding lines changed by exactly this ratio, so earlier share counts are restated.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (58)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Kenneth Fasola	Jul 5, 2024	78,970 shares, last reported balance as of Jul 4, 2024
Lori Robinson	May 16, 2024	11,455 shares, last reported balance as of May 14, 2024
David Thomas	Dec 19, 2023	132,941 shares, last reported balance as of Dec 15, 2023
James Murray	Jun 27, 2023	202,883 shares, last reported balance as of Jun 23, 2023
William Trubeck	Apr 4, 2023	94,824 shares, last reported balance as of Mar 31, 2023
Richard GEPHARDT	Feb 14, 2023	20,905 shares, last reported balance as of Dec 21, 2022
Brent Layton	Dec 13, 2022	562,853 shares, last reported balance as of Dec 10, 2022
Mark Brooks	Sep 20, 2022	153,755 shares, last reported balance as of Sep 16, 2022
Colin Toney	Sep 20, 2022	52,123 shares, last reported balance as of Sep 16, 2022
Shannon Bagley	Aug 18, 2022	116,705 shares, last reported balance as of Aug 16, 2022
Orlando Ayala	Apr 28, 2022	77,202 shares, last reported balance as of Apr 26, 2022
Leslie Norwalk	Apr 4, 2022	381 shares, last reported balance as of Mar 31, 2022
Brandy Burkhalter	Mar 28, 2022	350,475 shares, last reported balance as of Mar 24, 2022
Michael Neidorff	Feb 14, 2022	7,184,821 shares, last reported balance as of Dec 28, 2021
John Roberts	Jan 4, 2022	349,567 shares, last reported balance as of Dec 31, 2021
Robert Ditmore	Jan 4, 2022	978,546 shares, last reported balance as of Dec 31, 2021
Tommy Thompson	Jan 4, 2022	384,930 shares, last reported balance as of Dec 31, 2021
David Steward	Oct 4, 2021	216,004 shares, last reported balance as of Sep 30, 2021
Jesse Hunter	Jun 15, 2021	486,792 shares, last reported balance as of Jun 11, 2021
Jeffrey Schwaneke	May 11, 2021	454,549 shares, last reported balance as of May 7, 2021
Christopher Isaak	Dec 17, 2020	23,127 shares, last reported balance as of Dec 15, 2020
Keith Williamson	Feb 6, 2020	174,049 shares, last reported balance as of Feb 4, 2020
Christopher Bowers	Jul 23, 2019	121,998 shares, last reported balance as of Jul 22, 2019
Cynthia Brinkley	Feb 7, 2019	164,848 shares, last reported balance as of Feb 5, 2019
Carol Goldman	Feb 13, 2017	151,264 shares, last reported balance as of Dec 28, 2016
Kenneth Baldwin	Dec 15, 2016	142,925 shares, last reported balance as of Dec 15, 2016
Vicki Escarra	Apr 28, 2016	27,554 shares, last reported balance as of Apr 26, 2016
Pamela Joseph	Apr 4, 2016	281,069 shares, last reported balance as of Mar 31, 2016
William Scheffel	Mar 3, 2016	276,724 shares, last reported balance as of Mar 1, 2016
Donald Imholz	Dec 11, 2015	253,196 shares, last reported balance as of Dec 11, 2015
Edmund Kroll	Feb 4, 2015	172,282 shares, last reported balance as of Feb 3, 2015
Jason Harrold	Feb 4, 2015	160,650 shares, last reported balance as of Feb 3, 2015
Robert Hitchcock	Feb 4, 2015	88,327 shares, last reported balance as of Feb 3, 2015
David Minifie	Feb 4, 2015	78,958 shares, last reported balance as of Feb 3, 2015
Mary Mason	Feb 1, 2013	139,722 shares, last reported balance as of Dec 31, 2012
Karen Bedell	Dec 17, 2012	157,277 shares, last reported balance as of Dec 14, 2012
Mark Eggert	Feb 15, 2012	374,015 shares, last reported balance as of Feb 14, 2012
Frederick Manning	Dec 16, 2010	72,316 shares, last reported balance as of Dec 14, 2010
Antonette Simonetti	Dec 16, 2010	43,508 shares, last reported balance as of Dec 14, 2010
Steve Bartlett	Apr 1, 2010	236,736 shares, last reported balance as of Mar 31, 2010
Cary Hobbs	Dec 18, 2009	71,322 shares, last reported balance as of Dec 16, 2009
Eric Slusser	Oct 19, 2009	167,016 shares, last reported balance as of Oct 16, 2009
Marie Glancy	Dec 14, 2007	44,956 shares, last reported balance as of Dec 14, 2007
Per Brodin	Dec 14, 2007	43,348 shares, last reported balance as of Dec 12, 2007
Patti Darnley	Dec 14, 2007	54,252 shares, last reported balance as of Dec 13, 2007
Karey Witty	Dec 14, 2006	216,000 shares, last reported balance as of Dec 12, 2006
Joseph Drozda Jr.	Dec 14, 2006	127,124 shares, last reported balance as of Dec 12, 2006
Lisa Wilson	Dec 14, 2006	65,800 shares, last reported balance as of Dec 12, 2006
Glendon Schuster	Dec 14, 2006	12,800 shares, last reported balance as of Dec 12, 2006
James Donovan Jr.	Dec 15, 2005	9,876 shares, last reported balance as of Dec 13, 2005
Brian Spanel	Jun 24, 2005	745,784 shares, last reported balance as of Jun 24, 2005
Richard Wiederhold	Apr 28, 2005	417,660 shares, last reported balance as of Apr 26, 2005
Samuel Bradt	Mar 1, 2005	829,344 shares, last reported balance as of Feb 25, 2005
Dan Paquin	Feb 14, 2005	No balance on record
John Tadich	Dec 2, 2004	No balance on record
Claire Johnson	May 4, 2004	2,806,672 shares, last reported balance as of May 4, 2004
Catherine Halverson	Jan 16, 2004	No balance on record
Edward Cahill	Dec 22, 2003	72,000 shares, last reported balance as of Dec 22, 2003

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Centene Corporation insiders sold $14.6M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Common questions

Is the Centene Corporation CEO selling stock?

Why are Centene Corporation insiders selling?

Are any Centene Corporation insiders buying?

How much of their stake did Centene Corporation insiders sell?

The evidence

No plan disclosed · $14.6M

Taxes

Sales by month